“…Cyclophosphamide, methotrexate (MTX), vincristine (VCR), and other chemotherapeutic agents are responsible for several side effects on cognitive, neurological, and motor functions, which negatively impact patients’ development. Patients with leukemia and lymphoma are at risk for developing complications such as decreases in muscular strength, impaired gross and fine motor skills, osteonecrosis, and fatigue . These outcomes are evident at diagnosis and especially at an early stage of treatment .…”